357 filings
Page 13 of 18
6-K
TRIL
Trillium Therapeutics Inc.
11 Oct 17
Trillium Therapeutics Welcomes DR. Helen Tayton-martin to Its Board of Directors
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
14 Sep 17
Trillium Therapeutics to Present at Investor and Scientific Conferences In September
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
11 Aug 17
Interim Condensed Consolidated Financial Statements
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
5 Jul 17
Trillium Provides Update on Small Molecule Programs
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
28 Jun 17
Trillium Announces Partial Exercise of Over-allotment Option
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
13 Jun 17
Form 51-102F3 Material Change Report
12:00am
SC 13D
TRIL
Trillium Therapeutics Inc.
9 Jun 17
Trillium Therapeutics Inc.
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
7 Jun 17
Current report (foreign)
12:00am
SC 13G
Cormorant Asset Management, LP
5 Jun 17
Trillium Therapeutics Inc.
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
1 Jun 17
Trillium Closes US$30 Million Public Offering of Common Shares and Series Ii Non-voting Convertible First Preferred Shares
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
31 May 17
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
26 May 17
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
26 May 17
Trillium Announces Pricing of US$30.0 Million Public Offering of Common Shares and Series Ii Non-voting Convertible First Preferenceshares
12:00am
SUPPL
TRIL
Trillium Therapeutics Inc.
26 May 17
Supplemental materials (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
25 May 17
Trillium Announces Proposed Public Offering
12:00am
SUPPL
TRIL
Trillium Therapeutics Inc.
25 May 17
Supplemental materials (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
12 May 17
Interim Condensed Consolidated Financial Statements
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
20 Apr 17
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
3 Apr 17
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
29 Mar 17
Trillium Therapeutics to Present at Investor and Scientific Conferences In April
12:00am